from Reuters: Health News https://reut.rs/2RcfIuD
Wednesday, December 26, 2018
Wednesday, December 26, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
The U.S. Food and Drug Administration on Friday approved Stemline Therapeutics Inc's Elzonris for the treatment of a rare blood disease in adults and children aged two years and above.

from Reuters: Health News https://reut.rs/2RcfIuD
from Reuters: Health News https://reut.rs/2RcfIuD
Related Posts:
LATEST HEALTH NEWS(Reuters Health) - Most doctors who treat young athletes for concussion know that the injury increases the risk of having a car accident, but barely half counsel their patients against driving, a U.S. study suggests. fro… Read More
LATEST HEALTH NEWS(Reuters Health) - Middle-aged adults who lose most of their net worth over a brief period of time are more likely to die prematurely than individuals who hold on to their nest eggs, a U.S. study suggests. from Reuters: … Read More
LATEST HEALTH NEWSSEOUL (Reuters) - South Koreans who enjoy a rare flavor of soju, the country's most beloved alcohol, have been discouraged from mixing wasps into their drinks as a tonic after a health warning from the food ministry. fro… Read More
LATEST HEALTH NEWS(Reuters Health) - Mothers of babies with heart defects are themselves at higher-than-average risk for being hospitalized with heart disease later in life, researchers say. from Reuters: Health News https://ift.tt/2uKuVs… Read More
LATEST HEALTH NEWSOsteopenia is a condition in which bone mineral density is lower than normal from Health https://ift.tt/2uxsPMI … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment